Background. Invasive sinonasal aspergillosis is a serious infection that occurs in immunocompromised hosts. Patients with HIV/AIDS represent a minority of such cases in the literature in comparison to those with neutropenia due to malignancy and chemotherapy, diabetes, and corticosteroid use. The purpose of this study is to describe the clinical manifestations and treatment outcomes of invasive sinonasal aspergillosis among patient with HIV infection.
Methods. A PubMed search was conducted for English-language articles using search terms relating to aspergillus, HIV/AIDS, sinusitis, and central nervous system infection. Reference lists of those studies selected were also reviewed for eligible articles. Only those cases of aspergillosis originating from the paranasal sinuses were included in the analysis, in order to compare characteristics of invasion and outcome.
Results. Eighteen articles were found totaling 48 patients with HIV infection and invasive sinonasal aspergillosis. The average patient age was 37 (range 30 to 50), and 36 (75%) were men. Of the 38 patients in whom immunologic parameters were reported, all had AIDS and 32 (84%) had a CD4 count less than 50 at the time of diagnosis of aspergillosis. All cases were due to Aspergillus fumigatus among those that were reported. The most common symptoms were fever (35%), headache (32%), proptosis (29%) and facial pain (26%). Thirty-five patients had imaging data reporting sinus involvement, the most common of which were the maxillary and ethmoid sinuses (46% respectively) followed by the sphenoid sinus (26%). The most common intracranial site of invasion was the orbit and periorbit (46%). Thirty-two (89%) of 36 patients underwent surgery after diagnosis, while all patients received anti-fungal therapy. Two of 31 patients with reported data received itraconazole alone, while the remainder received amphotericin B either alone or in combination or consecutively with itraconazole. Among 44 cases with reported outcomes, the mortality was 91%.
Conclusion. Invasive sinonasal aspergillosis is a lethal infection in patients with advanced HIV/AIDS. Clinicians must consider this disease in HIV-infected patients presenting with fever, headache, and proptosis, and initiate early antifungal therapy and surgical debridement when appropriate.
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